Camerlinck Robert's Form 4 filing
Cano Health, Inc. (CANO) · filed Apr 10, 2023
- Accession no.
- 0000950170-23-012350
- Filed
- Apr 10, 2023, 9:40 PM ET
- Trade date
- Apr 5, 2023
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 3 derivative transactions. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Camerlinck RobertCIK 0001942114 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2023 | Class A Common Stock | JOtherAcquired | +2,836,540 | –F1 | – | 26,750,149 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2023 | Class A Common Stock | JOtherAcquired | +17,163,460 | –F4 | – | 17,163,460 | Direct | |
| Apr 5, 2023 | Class A Common Stock | JOtherAcquired | +17,163,460 | –F4 | – | 17,163,460 | Direct | |
| Apr 5, 2023 | Put option (obligation to sell) | SSaleDisposed | −20,000,000 | –F5 | – | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
In connection with the transfer described in Note (4) below, reflects the transfer of Class A Common Stock by a borrower to the Reporting Person pursuant to a repayment agreement to pay in full the outstanding principal amount owed by such borrower to the Reporting Person under an outstanding promissory note. For such purpose, the parties agreed that the price for the Class A Common Stock was $1.50 per share of Class A Common Stock.
Referenced by the price of 1 transaction in Table I.
- F4
In connection with the transfer described in Note (1) above, reflects the transfer of PCIH Common Units and an equal number of shares of Class B Common Stock (the "Transferred Securities") by borrowers to the Reporting Person pursuant to a repayment agreement to pay in full the outstanding principal amount owed by such borrowers to the Reporting Person under an outstanding promissory note. For such purpose, the parties agreed that the combined price for the Transferred Securities was $1.50 per share of Class B Common Stock.
Referenced by the price of 2 transactions in Table II.
- F5
In connection with the transfer described in Notes (1) and (4) above, the Reporting Person wrote an option to the borrowers under which the borrowers received a right to acquire the Transferred Securities and the Class A Common Stock described in footnote (1) above from the Reporting Person for a price equal to $3.00 per share of Class B Common Stock or Class A Common Stock, as applicable, exercisable during the one year period following April 5, 2023, subject to the terms and conditions of the repayment agreement referred to in Notes (1) and (4) above.
Referenced by the price of 1 transaction in Table II.